Cyclic nucleotides, prostaglandins and polyamines in psoriasis.
D001095:Arachidonic Acids / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects; D046508:Culture Techniques; D000242:Cyclic AMP / Q000378:metabolism / Q000502:physiology*; D006152:Cyclic GMP / Q000378:metabolism / Q000502:physiology*; D000078404:Epidermal Cells; D004817:Epidermis / Q000378:metabolism; D004837:Epinephrine / Q000494:pharmacology; D006706:Homeostasis; D006801:Humans; D009712:Nucleotides, Cyclic / Q000494:pharmacology; D011073:Polyamines / Q000502:physiology*; D011453:Prostaglandins / Q000378:metabolism / Q000502:physiology*; D011458:Prostaglandins E / Q000096:biosynthesis; D011565:Psoriasis / Q000378:metabolism*; D011943:Receptors, Adrenergic, beta / Q000502:physiology; D012867:Skin / Q000378:metabolism
D001095:Arachidonic Acids; D009712:Nucleotides, Cyclic; D011073:Polyamines; D011453:Prostaglandins; D011458:Prostaglandins E; D011943:Receptors, Adrenergic, beta; D000242:Cyclic AMP; D006152:Cyclic GMP; D004837:Epinephrine